Retatrutide 10mg
99.4% HPLC PurityA triple GLP-1, GIP and glucagon receptor agonist, supplied as a 10mg lyophilised vial.

SKU: PW-023 • Batch: PW-260301
Research-grade Retatrutide 20mg lyophilised powder. 99.4% HPLC purity, COA verified. Triple GLP-1/GIP/Glucagon receptor agonist for metabolic research.
Read the full description ↓✓Free shipping on orders over $250 AUD
✓Australia Post tracked — Standard $12.99 / Express $18.99
✓Dispatched next business day (orders before 11PM AEST)
A triple GLP-1, GIP and glucagon receptor agonist, supplied as a 10mg lyophilised vial.
Purity independently verified at a leading Australian university via HPLC & mass spectrometry.
Retatrutide (LY3437943) is a novel triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. This is the higher-strength 20mg vial, supplied as a lyophilised powder at 99.4% HPLC purity with full Certificate of Analysis (COA) documentation.
The material is identical to our 10mg vial — same GMP-certified sourcing, same chain-of-custody documentation, same independent third-party HPLC testing, mass spectrometry identity confirmation, LAL endotoxin assay (<1.0 EU/mg), and sterility screening before dispatch. The only difference is the mass in the vial.
The 20mg format suits research programs running longer protocols or larger sample counts, where fewer vials means fewer reconstitution steps and less packaging per milligram.
Only in the mass per vial. Both are the same research-grade Retatrutide (LY3437943) at 99.4% HPLC purity from the same GMP-certified source, with the same COA testing. The 20mg vial simply contains twice as much material.
Add 2–4mL of bacteriostatic water slowly to the vial. Gently swirl; do not shake. Allow the lyophilised powder to dissolve completely before use in research protocols.
Store lyophilised at −20°C for long-term stability. Once reconstituted with bacteriostatic water, store at 2–8°C and use within 4 weeks. Avoid repeated freeze-thaw cycles.
Yes. Every batch ships with a downloadable COA including HPLC purity percentage, mass spectrometry identity confirmation, sterility results, and LAL endotoxin assay data.
Retatrutide 20mg is sold strictly for in-vitro laboratory and research purposes only. This product is not intended for human consumption, therapeutic use, cosmetic use, or veterinary application. It has not been evaluated by the Therapeutic Goods Administration (TGA) or any other regulatory body for human use. You must be 18 years of age or older to purchase. By purchasing, you confirm that you are a qualified researcher and will use this product in compliance with all applicable Australian laws and regulations.
No questions yet — be the first to ask about this product.
The same Retatrutide powder as our vials, sold by the gram for larger research programs.
A dual GIP and GLP-1 receptor agonist, supplied as a 10mg lyophilised vial.